TNF and myeloid sarcoma: The side effects of this class of therapeutics may be less severe than those associated with global TNF blockers that neutralize sTNF and tmTNF and may be effective therapeutic for other diseases, including multiple sclerosis (MS) and neurodegenerative diseases, where it is not recommended to completely inhibit TNF [71].